About Us
Canadian Liver Meeting 2022
May 13 – 15, 2022 - Join In-Person & Online
5th Global NASH CONGRESS
6 reasons to come
- Learn how to integrate NAFLD Screening into secondary and tertiary care
- Discover the regulatory pathways for approval of biomarkers in NAFLD patients
- Review the current and potential biomarkers for staging
- Investigate if targeting fructose metabolism offers a NAFLD/NASH therapy
- Hear how belapectin, a galectin-3 (Gal-3) inhibitor, is in development for the prevention of oesophagal varices in patients with NASH cirrhosis
- Explore the Epidemiology of NAFLD
A discount code for a 15% discount is FATLI15